Skip to content

Analgesic Effect of Liposomal Bupivacaine vs Ropivacaine for Adductor Canal Block Combined with iPACK Block in Total Knee Arthroplasty: A Prospective, Double-blind, Randomized Controlled Trial

Analgesic Effect of Liposomal Bupivacaine vs Ropivacaine for Adductor Canal Block Combined with iPACK Block in Total Knee Arthroplasty: A Prospective, Double-blind, Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500096662
Enrollment
Unknown
Registered
2025-01-27
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee diseases

Interventions

Liposomal Bupivacaine group:use Liposomal Bupivacaine to perform Adductor Canal Block Combined with iPACK Block
Ropivacaine group:use Ropivacaine to perform Adductor Canal Block Combined with iPACK Block

Sponsors

Shanghai East Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Age < 80 years; 2.Scheduled for unilateral TKA for the first time; 3.The American Society of Anesthesiologists (ASA) Physical Status I-III.

Exclusion criteria

Exclusion criteria: (1) Patients undergoing emergency surgery; (2) Those with hypertension, diabetes, etc. and uncontrolled; (3) History of neurological diseases such as stroke and epilepsy; (4) Combined with severe liver and kidney damage, heart failure, malignant tumors, etc.; (5) Long-term use of analgesic drugs; (6) Infection at the puncture site; (7) Mental illness that cannot cooperate with the study; (8) Those who are allergic to the drugs used in the study; (9) Patients who are pregnant, breastfeeding or trying to become pregnant; (10) Diabetic neuropathy, coagulation or bleeding disorders, severe peripheral vascular diseases, etc.; (11) Has participated in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Visual analog scale;

Secondary

MeasureTime frame
The first time the analgesic pump is pressed and the total number of presses within 48 hours;First use time, total dosage, and salvage analgesia rate of opioid drugs (hydrocodone);Total consumption of opioid drugs;Time of first straight leg elevation;Postoperative hospitalization time;Intraoperative changes in mean arterial pressure and heart rate;Remedial analgesia rate;

Countries

China

Contacts

Public ContactShen Wang

Shanghai East Hospital

shenw99@126.com+86 198 5177 6566

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026